Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying.
Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.
A microcontroller platform for the rapid prototyping of functional electrical stimulation-based gait neuroprostheses.
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing- remitting multiple sclerosis.
Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.
Retinal hemorrhages following fingolimod treatment for multiple sclerosis; a case report.
Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS.
Ozanimod: a better or just another S1P receptor modulator?
Aquaporin-4 autoimmunity in a child without optic neuritis and myelitis.
Care ethics for guiding the process of multiple sclerosis diagnosis.
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation.
6.7-kbp deletion in LILRA3 (ILT6) gene is associated with later onset of the multiple sclerosis in a Polish population.
A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
Epileptic seizures in multiple sclerosis: a population-based survey in Iran.
MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.
[Natalizumab as induction therapy in multiple sclerosis.]
Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL/J6 Mouse Model.
Secondary Health Conditions in Individuals With Multiple Sclerosis: A Cross-Sectional Web-Based Survey Analysis.
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Timing of cigarette smoking as a risk factor for multiple sclerosis.
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
High-Content Phenotypic Screening and Triaging Strategy to Identify Small Molecules Driving Oligodendrocyte Progenitor Cell Differentiation.
High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.
Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.
Pages
« first
‹ previous
…
416
417
418
419
420
421
422
423
424
…
next ›
last »